African Black Eczema Therapy
NDC Package 58666-3124-5
Package Information
African Black Eczema Therapy is a . Marketed by Sundial Group Llc, this product is identified by NDC 58666-3124.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58666 - Sundial Group Llc
- 58666-3124 - African Black Eczema Therapy
- 58666-3124-5 - 141 g in 1 PACKAGE
- 58666-3124 - African Black Eczema Therapy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58666-3124-5 identifies a specific commercial package of 141 g in 1 package of African Black Eczema Therapy, labeled by Sundial Group Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sundial Group Llc on May 21, 2020. The current certification is valid through March 01, 2026.
How is this Sundial Group Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58666312405. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.